Dashboard
Manage Tickers

IDYA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

oracle-to-rally-around-29-here-are-10-top-analyst-forecasts-for-tuesday
Oracle To Rally Around 29%? Here Are 10 To...
09/10/2024 12:37:25

stifel-maintains-buy-on-ideaya-biosciences-raises-price-target-to-68
Stifel Maintains Buy on IDEAYA Biosciences...
09/10/2024 11:21:15

Stifel analyst Benjamin Burnett maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $63 t...

citigroup-maintains-buy-on-ideaya-biosciences-lowers-price-target-to-58
Citigroup Maintains Buy on IDEAYA Bioscien...
08/27/2024 14:36:59

Citigroup analyst Yigal Nochomovitz maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $...

jp-morgan-maintains-overweight-on-ideaya-biosciences-lowers-price-target-to-66
JP Morgan Maintains Overweight on IDEAYA B...
08/08/2024 16:15:19

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from ...

rbc-capital-reiterates-outperform-on-ideaya-biosciences-maintains-61-price-target
RBC Capital Reiterates Outperform on IDEAY...
08/07/2024 16:33:43

RBC Capital analyst Gregory Renza reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $61 price target.

wedbush-reiterates-outperform-on-ideaya-biosciences-maintains-54-price-target
Wedbush Reiterates Outperform on IDEAYA Bi...
08/07/2024 14:32:10

Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $54 price target.

oppenheimer-maintains-outperform-on-ideaya-biosciences-lowers-price-target-to-53
Oppenheimer Maintains Outperform on IDEAYA...
08/07/2024 11:51:57

Oppenheimer analyst Matthew Biegler maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target...

ideaya-biosciences-cash-cash-equivalents-and-marketable-securities-as-of-june-30-of-9527m-anticipated-to-fund-operations-into-at-least-2028
IDEAYA Biosciences Cash, Cash Equivalents ...
08/06/2024 10:06:52

ideaya-biosciences-q2-2024-gaap-eps-068-misses-054-estimate
IDEAYA Biosciences Q2 2024 GAAP EPS $(0.68...
08/06/2024 10:05:33

ideaya-biosciences-announced-that-it-has-entered-into-an-option-and-license-agreement-for-a-potential-first-in-class-b7h3ptk7-bsadc-program-with-biocytogen-pharmaceuticals-beijing-co
IDEAYA Biosciences Announced That It Has E...
07/31/2024 10:04:15

jp-morgan-maintains-overweight-on-ideaya-biosciences-raises-price-target-to-69
JP Morgan Maintains Overweight on IDEAYA B...
07/12/2024 15:06:11

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and raises the price target from ...

rbc-capital-maintains-outperform-on-ideaya-biosciences-raises-price-target-to-61
RBC Capital Maintains Outperform on IDEAYA...
07/11/2024 14:53:04

RBC Capital analyst Gregory Renza maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target f...

why-seastar-medical-holding-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why SeaStar Medical Holding Shares Are Tra...
07/10/2024 17:18:59

kura-sushi-posts-weak-q3-results-joins-legalzoomcom-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Kura Sushi Posts Weak Q3 Results, Joins Le...
07/10/2024 12:01:12

reported-earlier-ideaya-prices-263m-public-offering-of-228572-common-shares-and-pre-funded-warrants-at-35share
Reported Earlier, IDEAYA Prices $263M Publ...
07/10/2024 06:32:51

IDEAYA is selling 7,228,572 shares of common stock and pre-funded warrants to purchase 285,715 shares of common stock in the ...

ideaya-biosciences-intends-to-offer-up-to-200m-of-shares-of-its-common-stock-and-in-lieu-of-common-stock-to-offer-certain-investors-pre-funded-warrants
IDEAYA Biosciences Intends To Offer Up To ...
07/09/2024 20:10:50

btig-maintains-buy-on-ideaya-biosciences-raises-price-target-to-62
BTIG Maintains Buy on IDEAYA Biosciences, ...
07/09/2024 16:36:09

BTIG analyst Justin Zelin maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $55 to $62.

stifel-maintains-buy-on-ideaya-biosciences-maintains-63-price-target
Stifel Maintains Buy on IDEAYA Biosciences...
07/08/2024 17:54:31

Stifel analyst Benjamin Burnett maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and maintains $63 price target.

oppenheimer-maintains-outperform-on-ideaya-biosciences-raises-price-target-to-60
Oppenheimer Maintains Outperform on IDEAYA...
07/08/2024 17:52:01

Oppenheimer analyst Matthew Biegler maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target...

why-arhaus-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Arhaus Shares Are Trading Lower By Aro...
07/08/2024 17:16:55

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION